Shares of Spanish biotech company Oryzon Genomics plummeted more than 23 percent after Swiss drug giant Roche ended a three-year-old developmental deal for the company’s leukemia and cancer treatments.
French drugmaker Sanofi boosted its early-stage pipeline in immunology by signing a deal with Ablynx that could earn the Belgian biotech firm as much as 2.4 billion euros ($2.8 billion).
People who typically work much more than 35 to 40 hours a week may be at heightened risk of developing atrial fibrillation, an irregular rapid heartbeat that can lead to strokes, heart failure and chronic fatigue, a recent study suggests.
A psychiatric hospital in Belgium is home to one of the world’s largest collections of human brains, which researchers say could hold the key to developing new treatments for diseases such as psychosis, schizophrenia and severe depression.
The European Medicines Agency (EMA), eager to accelerate access to promising new drugs, may be getting too cozy with the pharmaceutical companies it regulates.
Siemens Healthineers broke ground on a $300 million expansion at its Massachusetts-based laboratory diagnostics, manufacturing and research and development facility.
Novartis CEO Joe Jiminez spoke with investors and analysts regarding the company’s half-year financials.
As their seven-year effort to repeal and replace Obamacare derailed in the U.S. Senate, Republicans faced the prospect of doing the once unthinkable: working with Democrats to make fixes to former President Barack Obama’s 2010 healthcare law.
The FDA approved Gilead Sciences’ Vosevi, an oral medicine for the re-treatment of chronic HCV.
Vertex Pharmaceuticals announced positive efficacy data from its Phase I and Phase II studies of three different triple combination regimens for cystic fibrosis patients,
NKTR-181 shows significantly less abuse potential compared to oxycodone.
The FDA approved Puma Biotechnology’s breast cancer drug Nerlynx (neratinib).
The FDA is tackling a new way to recruit top talent — talent that will fill a “substantial” number of vacant position.
July 18, 2017 By Mark Terry, BioSpace.com Breaking News Staff Chicago, Ill. – Takeda Pharmaceuticals (TKPYY) is shifting hundreds of executives from the Chicago area to relocate to Boston. It is also cutting hundreds of field sales positions throughout the U.S. In March, the company indicated it was making job cuts in the Cambridge, […]
THIRUVANANTHAPURAM, India (Reuters) – A dengue outbreak has killed at least 21 people in India’s southern state of Kerala in the past three weeks, a government official said, adding that there was a shortage of medicines and health workers to tackle the crisis in the tourist hotspot. The mosquito-borne dengue virus, which causes flu-like symptoms […]
By Jilian Mincer Bay Minette, Alabama (Reuters) – Dr. Nicole Arthur, a family practice physician, was trained to avoid Cesarean deliveries in child-birth, unless medically necessary, because surgery increases risks and recovery time. But she has adjusted her approach since arriving last year at the 70-bed North Baldwin Infirmary in rural, southern Alabama. Low patient […]
By Susan Cornwell WASHINGTON (Reuters) – U.S. Senate Republicans will vote on a straight repeal of Obamacare after efforts to overhaul the law collapsed, rattling financial markets on Tuesday and clouding the path forward for President Donald Trump’s other domestic policy goals. After two Republicans said they would not back the latest Obamacare […]
UDG Healthcare plc announced the acquisition of Cambridge BioMarketing LLC, a U.S.-based healthcare communications business, for a total consideration of up to $35 million.
People hoping to lose a few pounds by substituting artificial sweeteners for regular sugar may end up disappointed, suggests a fresh look at past research.
Fingerpaint, a full-service marketing agency with offices in Arizona, Pennsylvania, New York and Ohio, named a longtime creative duo as the new leaders of the agency’s creative team. Katie Beller and Andy Spitzer will be based in the agency’s headquarters in Saratoga Springs, New York.